The generalizable technique could lead to repurposing thousands of commercial protein products, including antibodies, for biological research and therapeutic applications. The group's paper ...

"We are thrilled to complete this Transaction ahead of schedule and begin integrating Burcon's technologies into the facility," said John Vassallo, a Burcon director. "The Galesburg facility was our ...